Patents by Inventor Mark Meerson

Mark Meerson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220223227
    Abstract: Techniques for identifying malignant cell populations. The techniques include: obtaining sequencing data previously obtained from a biological sample from a subject; processing the sequencing data to identify: a plurality of cell population estimates for a cell of a first type, the plurality of cell population estimates including a first cell population estimate and a second cell population estimate associated respectively with largest and second largest cell population estimates from among the identified plurality of cell population estimates; and features associated with the plurality of cell population estimates, the features including: a first feature indicative of a size of the first cell population estimate; and a second feature indicative of a ratio between sizes of the first cell population estimate and the second cell population estimate; and determining, using the features and a trained machine learning model, whether the first cell population estimate includes malignant cells of the first type.
    Type: Application
    Filed: December 16, 2021
    Publication date: July 14, 2022
    Applicant: BostonGene Corporation
    Inventors: Olga Kudryashova, Mark Meerson, Vasiliy Minkov, Nikita Kotlov, Feliks Frenkel
  • Publication number: 20220186318
    Abstract: Aspects of the disclosure relate to methods, systems, computer-readable storage media, and graphical user interfaces (GUIs) that are useful for characterizing subjects having certain cancers, for example lymphomas. The disclosure is based, in part, on methods for determining the tumor microenvironment (TME) type of a lymphoma (e.g., follicular lymphoma) subject and identifying the subject's prognosis based upon the TME type determination.
    Type: Application
    Filed: December 10, 2021
    Publication date: June 16, 2022
    Applicant: BostonGene Corporation
    Inventors: Mark Meerson, Nikita Kotlov, Olga Kudryashova, Alexander Bagaev